
Csaba Gajdos MD, FACS, FSSO
@csabagajdos1
Surgical Oncologist @UBSurgery | Professor @jacobs_me_ub | #SurgicalOutcomes | 🏒👨👩👦👦 l @asochat | @UABSurgery | @UMichSurgery
ID: 883827214126645249
https://medicine.buffalo.edu/faculty/profile.html?ubit=csabagaj 08-07-2017 23:16:43
238 Tweet
423 Followers
1,1K Following

December Issue: Clinical Outcomes, Costs, and Value of Surgery Among Older Patients with #ColonCancer at US News and World Report Ranked Versus Unranked Hospitals Abdullah Altaf, MD Timothy M. Pawlik Muhammad Muntazir Mehdi Khan rdcu.be/d19RN @csabagajdos1 Syed A. Ahmad




Whipple with portal vein reconstruction Jacobs School at University at Buffalo Kaleida Health Department of Surgery | University at Buffalo Michigan Surgery UAB Surgery Ahmad Zaaroura


January Issue: Minimally Invasive Surgery: Is It a Risk Factor for Postoperative #PeritonealMetastasis in pT4 #ColonCancer ? rdcu.be/d7HIj @jeffreyfarma Syed A. Ahmad


📢 Join us for the next #ASOChat! Awesome lineup of special guests to discuss PRRT, surgical debulking, and more! Looking forward to many jumping in to chat 💯 Tracey Pu, MD Csaba Gajdos MD, FACS, FSSO Sabha Ganai MD PhD MPH FACS FSSO 🐲🇵🇸 Kurt Schultz Syed A. Ahmad Society of Surgical Oncology


Anthony Villano, MD Annals of Surgical Oncology Paging Stefano Partelli, my go-to expert on the subject. He led the NEOLUPANET phase 2 trial. Preoperative PRRT certainly safe and can be done but will it improve overall outcomes as well as resectability? With the ORR seen, certainly something to think about


Anthony Villano, MD Annals of Surgical Oncology Retrospective data from the Netherlands also intriguing. Downstaging following PRRT is clearly possible, even at the tumor - vessel interface.


Annals of Surgical Oncology James Howe Acknowledging it’s an uncommon manifestation, but has there been any experience with peritoneal metastases of NET? Does response to PRRT differ for those with peritoneal disease? Any role for debulking prior to PRRT? #ASOchat

“Yes, both SBNET and PNET patients had statistically significant improvements in PFS with PRRT, and OS was very close in SBNET patients (P=0.06). Smaller numbers may have contributed.” - Dr. Howe (James Howe) #ASOchat



Our partnership with Dr. Glaucomflecken continues as he summarizes the final, 10-year outcomes of the CheckMate 067 trial, which investigated nivolumab plus ipilimumab in advanced melanoma. Access the article for free: nej.md/42V5Pps

18s wrapped up Nationals prep today. 1st game tomorrow in Pittsburgh at 515 vs Anaheim. Thank you to our sponsor john j fromen jr for supporting the team this year #rollstorm


May Issue: Predictors of Pathologic Non-response to Neoadjuvant Approaches in Locally Advanced #RectalCancer Jyi Cheng Ng Richard Sassun M.D. rdcu.be/elJ6E @csabagajdos1 Syed A. Ahmad

#AudioVisualAbstract : Outcomes of Distal #RectalCancer Patients Who Did Not Qualify for Watch-and-Wait: Comparison of Intersphincteric Resection Versus Abdominoperineal Resection. yael Julio Garcia Aguilar rdcu.be/ewQz4 @csabagajdos1 Syed A. Ahmad